8-K 1 utmed8kmay2004.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 10, 2004 Commission File No. 0-11178 ------- UTAH MEDICAL PRODUCTS, INC. (Exact name of Registrant as specified in its charter) UTAH 87-0342734 ----------------------------------- ------------------ (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 7043 South 300 West Midvale, Utah 84047 Address of principal executive offices Registrant's telephone number: (801) 566-1200 -------------- ------------------------------------------------------------------------------- ITEM 5. OTHER EVENTS ------------------------------------------------------------------------------- On May 10, 2004, Utah Medical Products, Inc. announced that it is instituting a regular quarterly cash dividend. The initial dividend of $.15 per share is payable on July 5, 2004 to shareholders of record at the close of business on June 16, 2004. A copy of the press release is attached hereto as Exhibit 99.1. ------------------------------------------------------------------------------- SIGNATURES ------------------------------------------------------------------------------- Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. REGISTRANT Date: 5/11/2004 By: /s/ Kevin L. Cornwell --------------------------------- ----------------------------- Kevin L. Cornwell CEO ------------------------------------------------------------------------------- EXHIBIT INDEX Index Number Description 99.1 Press release issued May 10, 2004: Utah Medical Products, Inc. Institutes Quarterly Dividends